SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QLT PhotoTherapeutics (QLTI) -- Ignore unavailable to you. Want to Upgrade?


To: Ian@SI who wrote (368)1/5/1999 10:31:00 AM
From: Ian@SI  Read Replies (1) | Respond to of 1321
 
A 25% pop and no response!!!!

Is this just what everyone expected?

09:48 ET QLT PhotoTherapeutics Inc. (QLTIF) 29 +6 5/16 (+28%): Developer of proprietary pharmaceutical products for use in photodynamic therapy and the eye care unit of Novartis announced that analysis of a 24-month pivotal Phase III studies has shown that Visudyne therapy preserves vision in a significant number of patients with the "wet" form of age-related macular degeneration.